EODData

MEMBERSHIP REGISTER LOG IN

FRA, DMN: Diamyd Medical AB (publ)

30 Apr 2026
LAST:

0.0568

CHANGE:
 0.00		OPEN:
0.0568		HIGH:
0.0568		ASK:
0.0000		VOLUME:
0
CHG(%):
5.38		PREV:
0.0539		LOW:
0.0568		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Apr 260.05680.05680.05680.05680
29 Apr 260.05390.05390.05390.05390
28 Apr 260.05410.05410.05410.05410
27 Apr 260.05890.05890.05890.05890
24 Apr 260.06170.06170.06170.06170
23 Apr 260.07640.07640.07640.07640
22 Apr 260.08310.08310.08310.08310
21 Apr 260.08730.08730.08730.08730
20 Apr 260.08860.08860.08860.08860
17 Apr 260.08470.08470.08470.08470

PROFILE

Name:Diamyd Medical AB (publ)
About:Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes in adults (LADA); and Remygen, an immunomodulation therapy, that is in phase I/II clinical trial for the treatment of with type 1 diabetes, type 2 diabetes, and LADA. It has a research and development collaboration agreement with Juvenile Diabetes Research Foundation to develop DIAGNODE-3 Phase 3 trial in type 1 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was founded in 1984 and is headquartered in Stockholm, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:Kungsgatan 29, Stockholm, Sweden, 111 56
Website:https://www.diamyd.com
ISIN:SE0005162880
LEI:5493003NP2HNQDEKB804

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.61 
PEG Ratio:-1.31 
Price to Sales:972.41 
Price to Book:0.43 
Profit Margin:-27.54 
Operating Margin:-2,584.11 
Return on Assets:-0.40 
Return on Equity:-0.80 
Revenue:11.8K 
Shares:134.0M 
Market Cap:7.61M 

TECHNICAL INDICATORS

MA5:0.060.5%
MA10:0.0724.3%
MA20:0.0952.1%
MA50:0.841,384.9%
MA100:0.991,636.6%
MA200:0.961,588.7%
STO9:8.36 
STO14:2.91 
RSI14:39.90 
WPR14:-97.09 
MTM14:-0.03
ROC14:-0.37 
ATR:0.02 
Week High:0.0834.5%
Week Low:0.055.4%
Month High:0.16184.5%
Month Low:0.051,588.7%
Year High:1.803,069.0%
Year Low:0.055.4%
Volatility:441.50